IFP Advisors’s Bionano Genomics BNGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Hold
0
-$76 3327
2023
Q2
Hold
0
3364
2023
Q1
Hold
0
3105
2022
Q4
Sell
-31
Closed -$39K 4292
2022
Q3
$130K Hold
31
﹤0.01% 1676
2022
Q2
$130K Hold
31
﹤0.01% 1522
2022
Q1
$130K Buy
+31
New +$41.8K ﹤0.01% 1522
2021
Q4
Hold
0
2950
2021
Q3
Hold
0
2983
2021
Q2
Hold
0
2866
2021
Q1
Sell
-8
Closed -$45.1K 2793
2020
Q4
$15K Buy
+8
New +$2.99K ﹤0.01% 1891

Other funds holding BNGO

IFP Advisors's BNGO Position: Q3 2023 in Review

IFP Advisors held its Bionano Genomics (BNGO) position steady in Q3 2023 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3327.

IFP Advisors first reported a position in BNGO in Q4 2020 and has held it in 4 quarters since. The position peaked at $130K in Q3 2022. 46 funds tracked by Wall St. Rank hold BNGO as of Q3 2023.

  • IFP Advisors held 0 shares of Bionano Genomics worth $0 as of Q3 2023.
  • IFP Advisors left its Bionano Genomics share count unchanged in Q3 2023.
  • Bionano Genomics made up ﹤0.01% of IFP Advisors's portfolio in Q3 2023, its #3327 holding.
  • IFP Advisors first reported a position in Bionano Genomics in Q4 2020 and has held it in 4 quarters since.
  • IFP Advisors's Bionano Genomics position peaked at $130K in Q3 2022.
  • 46 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2023.

Based on IFP Advisors's 13F filing for Q3 2023, filed 12 Oct 2023.